文献速递基础与转化研究医学人工智能与信息学流行病学与生物统计

机器学习建模与验证预测脂肪肝病因:IMI DIRECT队列研究

Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts.
PubMed 文献 · PLoS Med · 2020-06-19

本研究基于IMI DIRECT多中心前瞻性队列的3029名欧洲裔成人基线数据,利用多组学与临床变量构建机器学习模型预测肝脏脂肪含量(<5%或≥5%)。包含所有组学和临床变量的模型交叉验证ROCAUC为0.84(95%CI 0.82,0.86;p<0.001),优于仅含9个临床变量的模型(ROCAUC 0.82,95%CI 0.81,0.83;p<0.001)。临床变量单独预测能力优于复杂组学变量,但组合后准确性最高。

要点

  • 多组学联合临床变量模型预测NAFLD的ROCAUC达0.84,优于已有无创工具。
  • 仅用9个临床可及变量的模型ROCAUC为0.82,临床变量预测能力优于组学变量。
  • 模型已整合为网页工具(predictliverfat.org)供社区使用。

核心结论

  • 临床与组学变量组合的模型预测肝脏脂肪含量准确性最高,ROCAUC为0.84。
  • 临床变量单独预测能力优于复杂组学变量,但组合后准确性提升。
  • 已开发网页工具供临床预测NAFLD使用。

研究设计与样本

  • 多中心前瞻性队列研究IMI DIRECT,纳入3029名欧洲裔成人(近期诊断T2D 795人,高风险2234人)。
  • 利用多组学(遗传、转录组、蛋白质组、代谢组)和临床变量作为输入特征。
  • 模型在1514名有MRI衍生肝脏脂肪含量(<5%或≥5%)的参与者中训练。
  • 采用LASSO进行特征选择,随机森林分析构建预测模型。

主要发现

  • 包含所有组学和临床变量的模型交叉验证ROCAUC为0.84(95%CI 0.82,0.86;p<0.001)。
  • 包含9个临床可及变量的模型ROCAUC为0.82(95%CI 0.81,0.83;p<0.001)。
  • IMI DIRECT预测模型优于现有无创NAFLD预测工具。

临床怎么用

  • 可借助网页工具(predictliverfat.org)使用临床变量预测NAFLD。
  • 临床变量模型可作为无创筛查工具,辅助早期识别NAFLD高危个体。

局限性

  • 分析仅限于居住在北欧的欧洲裔成人,外推至其他 ancestry 和环境暴露人群未知。
  • 预测结局为肝脏脂肪含量的二分类(<5%或≥5%),而非连续变量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is highly prevalent and causes serious health complications in individuals with and without type 2 diabetes (T2D). Early diagnosis of NAFLD is important, as this can help prevent irreversible damage to the liver and, ultimately, hepatocellular carcinomas. We sought to expand etiological understanding and develop a diagnostic tool for NAFLD using machine learning. METHODS AND FINDINGS: We utilized the baseline data from IMI DIRECT, a multicenter prospective cohort study of 3,029 European-ancestry adults recently diagnosed with T2D (n = 795) or at high risk of developing the disease (n = 2,234). Multi-omics (genetic, transcriptomic, proteomic, and metabolomic) and clinical (liver enzymes and other serological biomarkers, anthropometry, measures of beta-cell function, insulin sensitivity, and lifestyle) data comprised the key input variables. The models were trained on MRI-image-derived liver fat content (<5% or ≥5%) available for 1,514 participants. We applied LASSO (least absolute shrinkage and selection operator) to select features from the different layers of omics data and random forest analysis to develop the models. The prediction models included clinical and omics variables separately or in combination. A model including all omics and clinical variables yielded a cross-validated receiver operating characteristic area under the curve (ROCAUC) of 0.84 (95% CI 0.82, 0.86; p < 0.001), which compared with a ROCAUC of 0.82 (95% CI 0.81, 0.83; p < 0.001) for a model including 9 clinically accessible variables. The IMI DIRECT prediction models outperformed existing noninvasive NAFLD prediction tools. One limitation is that these analyses were performed in adults of European ancestry residing in northern Europe, and it is unknown how well these findings will translate to people of other ancestries and exposed to environmental risk factors that differ from those of the present cohort. Another key limitation of this study is that the prediction was done on a binary outcome of liver fat quantity (<5% or ≥5%) rather than a continuous one. CONCLUSIONS: In this study, we developed several models with different combinations of clinical and omics data and identified biological features that appear to be associated with liver fat accumulation. In general, the clinical variables showed better prediction ability than the complex omics variables. However, the combination of omics and clinical variables yielded the highest accuracy. We have incorporated the developed clinical models into a web interface (see: https://www.predictliverfat.org/) and made it available to the community. TRIAL REGISTRATION: ClinicalTrials.gov NCT03814915.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Atabaki-Pasdar N, Ohlsson M, Viñuela A, et al. Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts. PLoS Med. 2020. PMID: 32559194. doi:10.1371/journal.pmed.1003149

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。